Jan 25, 2023 | Clinical case

Compare your opinion with peers and Prof. Dr. Marek Babjuk

According to the EAU 2022 guidelines, Bladder EpiCheck, Cxbladder Monitor, ADXBLADDER, Xpert Bladder Cancer Monitor might be used to replace and/or postpone cystoscopy in the surveillance of

 

Submit your answer and read the opinion of Prof. Dr. Marek Babjuk

 

Other updates

Urinary biomarkers for the surveillance of NMIBC

Can urinary biomarkers help address some of the key limitations of cystoscopy and urine cytology in the surveillance of non-muscle-invasive bladder cancer (NMIBC)? Watch this expert presentation to discover how urinary biomarkers may support a more patient-centred and...

read more